SEC ownership of COLGATE PALMOLIVE CO

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000021665.

Comparable stake leader

VANGUARD CAPITAL MANAGEMENT LLC

Disclosed value leader

BlackRock, Inc.

Comparable rows

50/50

Latest evidence

01 Jun 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
50 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
VANGUARD CAPITAL MANAGEMENT LLC
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
01 Jun 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0000021665
Issuer location
New York, NY

Ownership snapshot

Top shareholders of COLGATE PALMOLIVE CO (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VANGUARD CAPITAL MANAGEME...
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
01 Jun 2026
13D/G 13F 3/4/5 Lead comparable stake: 7.5% 13D/G row: VANGUARD CAPITAL MANAGEMENT LLC Showing 1-8 of 50 holder rows.

Quick read

VANGUARD CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 7.5%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD CAPITAL MANAGEMENT LLC's linked filing trail.
Comparable ownership Top 5
VANGUARD CAPITAL MANAGEMENT LLC 7.5%
Jennifer Daniels 0.01%
Stanley J. Sutula III 0.01%
John Hazlin 0%
Betsy Fishbone 0%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VANGUARD CAPITAL MANAGEMENT LLC
13D/G 13F
Vanguard Capital Management · Company
7.5%
$5,148,256,443
60,404,276 shares
$0 31 Mar 2026
Jennifer Daniels
3/4/5
CLO and Secretary
0.01%
$8,879,501
91,681 shares
-$2,075,399 23 Feb 2026
Stanley J. Sutula III
3/4/5
Chief Financial Officer
0.01%
$7,244,263
74,648 shares
-$9,223,288 23 Feb 2026
John Hazlin
3/4/5
Chief Growth Officer
0%
$2,833,323
29,874 shares
-$1,978,211 23 Feb 2026
Betsy Fishbone
3/4/5
CLO and Secretary
0%
$1,994,977
23,407 shares
01 Jun 2026
Gregory Malcolm
3/4/5
EVP and Controller
0%
$1,935,499
22,197 shares
-$1,413,234 15 May 2026
Sally Massey
3/4/5
Chief People Officer
0%
$1,899,731
21,937 shares
-$2,357,981 07 May 2026
BlackRock, Inc.
13F
Company
13F
9%
$6,191,363,013
72,643,002 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to selling over the last 12 months. Net value: -$26,106,044.

Buys
$0
Insiders: 0
Sells
$26,106,044
Insiders: 7
Net
-$26,106,044
Shares: -277,134
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 277,134
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 10,899 $0 $955,045 -$955,045
3-6 0 264,998 $0 $25,050,939 -$25,050,939
6-9 0 1,237 $0 $100,061 -$100,061
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-20 of 25 reporting-owner rows connected to COLGATE PALMOLIVE CO. Open a relationship link for the CIK-to-CIK filing trail.

Rows
25
Largest Forms 3/4/5 holder
Noel R. Wallace
Net 12M change
-$26,106,046
Latest report
16 Jun 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Noel R. Wallace Chairman, President & CEO, Director $44,176,102 -$4,279,496 -8.8% Mixed 23 Feb 2026
Jennifer Daniels CLO and Secretary $8,879,501 -$2,075,399 -19% Mixed 23 Feb 2026
Philip G. Shotts Vice President and Controller $7,801,035 Mixed 16 May 2022
Panagiotis Tsourapas COO, Eur., APac, Afr Eur, Skin $7,760,816 -$4,778,437 -38% Mixed 23 Feb 2026
Stanley J. Sutula III Chief Financial Officer $7,244,263 -$9,223,288 -56% Mixed 23 Feb 2026
Shane Grant COO, Americas $6,177,555 Median 16 Jun 2026
John T. Cahill Director $5,503,556 Median 11 May 2026
Prabha Parameswaran Vice Chair $5,473,308 Mixed 12 Sep 2025
Patricia Verduin SVP, Global Technology $5,299,431 Mixed 07 Nov 2022
John P. Bilbrey Director $3,796,058 Median 11 May 2026
Lorrie M. Norrington Director $3,606,251 Median 11 May 2026
Stephen I. Sadove Director $2,843,954 Mixed 15 May 2023
John Hazlin Chief Growth Officer $2,833,323 -$1,978,211 -41% Mixed 23 Feb 2026
C. Martin Harris Director $2,089,583 Median 11 May 2026
Michael B. Polk Director $2,017,279 Mixed 15 May 2023
Betsy Fishbone CLO and Secretary $1,994,977 Median 01 Jun 2026
Gregory Malcolm EVP and Controller $1,935,499 -$1,413,234 -42% Mixed 15 May 2026
Sally Massey Chief People Officer $1,899,731 -$2,357,981 -55% Mixed 07 May 2026
John W. Kooyman Chief of Staff $1,674,129 Mixed 12 Sep 2024
Lisa Edwards Director $1,549,651 Median 11 May 2026

Recent insider transactions for COLGATE PALMOLIVE CO

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Shane Grant CL Common Stock Tax liability -24.4% -23,347 72,481 16 Jun 2026 Direct
Gregory Malcolm CL Common Stock Sale -14.5% $203,412 $88.44 -2,300 13,598 15 May 2026 Direct
Brian Newman CL Common Stock Award 37.4% 2,075 7,621 11 May 2026 Direct
Brian Newman CL Stock Option (Right to Buy) Award 2,424 2,424 11 May 2026 Direct
Kimberly A. Nelson CL Common Stock Award 21.7% 2,075 11,634 11 May 2026 Direct
Kimberly A. Nelson CL Stock Option (Right to Buy) Award 2,424 2,424 11 May 2026 Direct
Martina Hundmejean CL Common Stock Award 14.7% 2,075 16,206 11 May 2026 Direct
Martina Hundmejean CL Stock Option (Right to Buy) Award 2,424 2,424 11 May 2026 Direct
Lorrie M. Norrington CL Common Stock Award 5.16% 2,075 42,312 11 May 2026 Direct
Lorrie M. Norrington CL Stock Option (Right to Buy) Award 2,424 2,424 11 May 2026 Direct
C. Martin Harris CL Common Stock Award 6.78% 1,556 24,517 11 May 2026 Direct
C. Martin Harris CL Stock Option (Right to Buy) Award 2,424 2,424 11 May 2026 Direct
Lisa Edwards CL Common Stock Award 12.9% 2,075 18,182 11 May 2026 Direct
Lisa Edwards CL Stock Option (Right to Buy) Award 2,424 2,424 11 May 2026 Direct
Cahill John T. CL Common Stock Award 7.94% 2,075 28,216 11 May 2026 Direct
Cahill John T. CL Stock Option (Right to Buy) Award 2,424 2,424 11 May 2026 Direct
Christopher S. Boerner CL Common Stock Award 1,383 1,383 11 May 2026 Direct
Christopher S. Boerner CL Stock Option (Right to Buy) Award 2,020 2,020 11 May 2026 Direct
John P. Bilbrey CL Common Stock Award 5.5% 2,075 39,820 11 May 2026 Direct
John P. Bilbrey CL Stock Option (Right to Buy) Award 2,424 2,424 11 May 2026 Direct
Sally Massey CL Common Stock Sale -38.4% $751,633 $87.41 -8,599 13,785 07 May 2026 Direct
Lorrie M. Norrington CL Common Stock Award 0.74% 294 40,160 01 Apr 2026 Direct
Brian Newman CL Common Stock Award 3.94% 210 5,534 01 Apr 2026 Direct
John P. Bilbrey CL Common Stock Award 0.71% 266 37,665 01 Apr 2026 Direct
John Hazlin CL Common Stock Tax liability -20% -6,117 24,422 23 Feb 2026 Direct
John Hazlin CL Common Stock Award 72.2% 12,803 30,539 23 Feb 2026 Direct
Jennifer Daniels CL Common Stock Tax liability -12.1% -12,351 89,844 23 Feb 2026 Direct
Jennifer Daniels CL Common Stock Award 33.7% 25,742 102,195 23 Feb 2026 Direct
Gregory Malcolm CL Common Stock Tax liability -12.4% -2,260 15,898 23 Feb 2026 Direct
Gregory Malcolm CL Common Stock Award 52.7% 6,268 18,158 23 Feb 2026 Direct
Sally Massey CL Common Stock Tax liability -26.8% -8,206 22,384 23 Feb 2026 Direct
Sally Massey CL Common Stock Award 121.9% 16,805 30,590 23 Feb 2026 Direct
Stanley J. Sutula III CL Common Stock Tax liability -21% -19,746 74,320 23 Feb 2026 Direct
Stanley J. Sutula III CL Common Stock Award 69.8% 38,678 94,066 23 Feb 2026 Direct
Panagiotis Tsourapas CL Common Stock Tax liability -37.7% -13,081 21,629 23 Feb 2026 Direct
Panagiotis Tsourapas CL Common Stock Award 287% 25,742 34,710 23 Feb 2026 Direct
Noel R. Wallace CL Common Stock Tax liability -15.9% -68,252 361,921 23 Feb 2026 Direct
Noel R. Wallace CL Common Stock Award 46.6% 136,710 430,173 23 Feb 2026 Direct
Panagiotis Tsourapas CL Common Stock Sale -59% $1,467,111 $97.81 -15,000 10,415 12 Feb 2026 Direct
Panagiotis Tsourapas CL Common Stock Options Exercise 144% 15,000 25,415 12 Feb 2026 Direct
Panagiotis Tsourapas CL Stock Option (Right to Buy) Options Exercise -42.9% -15,000 19,938 12 Feb 2026 Direct
Panagiotis Tsourapas CL Common Stock Sale -77.1% $3,311,326 $94.61 -35,000 10,415 11 Feb 2026 Direct
Panagiotis Tsourapas CL Common Stock Options Exercise 336% 35,000 45,415 11 Feb 2026 Direct
Panagiotis Tsourapas CL Stock Option (Right to Buy) Options Exercise -50% -35,000 34,938 11 Feb 2026 Direct
John Hazlin CL Common Stock Sale -54.3% $1,978,211 $94.25 -20,989 17,645 10 Feb 2026 Direct
John Hazlin CL Common Stock Options Exercise 119% 20,989 38,634 10 Feb 2026 Direct
John Hazlin CL Stock Option (Right to Buy) Options Exercise -100% -20,989 0 10 Feb 2026 Direct
Gregory Malcolm CL Common Stock Sale -51.8% $1,209,822 $94.91 -12,747 11,879 06 Feb 2026 Direct
Gregory Malcolm CL Common Stock Options Exercise 107.3% 12,747 24,626 06 Feb 2026 Direct
Gregory Malcolm CL Stock Option (Right to Buy) Options Exercise -100% -12,747 0 06 Feb 2026 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .